WillScot Introduces Innovative Power Solution – Solar Power by WillScot 4-06-2025, 21:00

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

MERMEC and Hitachi Rail sign put option agreement for sale of signaling systems in France, Germany, and the UK 30-01-2024, 21:12